miR-449a enhances radiosensitivity through modulating pRb/E2F1 in prostate cancer cells

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Tumor Biology

• Publication date

  2016-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13277-015-4336-8PMID 26520443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MiR‐449a exerts tumor‐suppressive functions in human glioblastoma by targeting Myc‐associated zinc‐finger protein

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• MicroRNA-449a Inhibits Proliferation and Induces Apoptosis by Directly Repressing E2F3 in Gastric Cancer

  2015cited by this paper
• microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest

  2015cited by this paper
• MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A.

  2014cited by this paper
• Dynamic analysis of the combinatorial regulation involving transcription factors and microRNAs in cell fate decisions.

  2014cited by this paper
• miR-449a Regulates Proliferation and Chemosensitivity to Cisplatin by Targeting Cyclin D1 and BCL2 in SGC7901 Cells

  2014cited by this paper
• microRNA Expression and Biogenesis in Cellular Response to Ionizing Radiation

  2014cited by this paper
• Tumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells.

  2014cited by this paper
• MIR449A (microRNA 449a)

  2013cited by this paper
• Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma

  2013cited by this paper
• MicroRNA-449a Enhances Radiosensitivity in CL1-0 Lung Adenocarcinoma Cells

  2013cited by this paper
• p15PAF Is an Rb/E2F-Regulated S-Phase Protein Essential for DNA Synthesis and Cell Cycle Progression

  2013cited by this paper
• Radiosensitization in prostate cancer: mechanisms and targets

  2013cited by this paper
• MicroRNA-449a Is Downregulated in Non-Small Cell Lung Cancer and Inhibits Migration and Invasion by Targeting c-Met

  2013cited by this paper
• Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity

  2012cited by this paper
• Dynamical Behaviors of Rb-E2F Pathway Including Negative Feedback Loops Involving miR449

  2012cited by this paper
• Cellular Response to Ionizing Radiation: A MicroRNA Story

  2012cited by this paper
• miR-449a Regulates the Chondrogenesis of Human Mesenchymal Stem Cells Through Direct Targeting of Lymphoid Enhancer-Binding Factor-1

  2012cited by this paper
• E2F1 and RNA binding protein QKI comprise a negative feedback in the cell cycle regulation

  2011cited by this paper
• MicroRNA-449 in cell fate determination

  2011cited by this paper
• Sensitive to apoptosis gene protein regulates ionizing radiation-induced apoptosis.

  2011cited by this paper
• miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells

  2010cited by this paper
• E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis

  2010cited by this paper
• miR-449a targets HDAC-1 and induces growth arrest in prostate cancer

  2009cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A.

  2009cited by this paper
• Most mammalian mRNAs are conserved targets of microRNAs.

  2008cited by this paper
• RB silencing compromises the DNA damage-induced G2/M checkpoint and causes deregulated expression of the ECT2 oncogene

  2007cited by this paper
• MicroRNAs and Cell Cycle Regulation

  2007cited by this paper
• p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2

  2005cited by this paper
• Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy.

  2005cited by this paper
• Cell lines used in prostate cancer research: a compendium of old and new lines--part 1.

  2005cited by this paper
• Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.

  2005cited by this paper
• Role of cell cycle in mediating sensitivity to radiotherapy.

  2004cited by this paper
• Molecular characterization of human prostate carcinoma cell lines

  2003cited by this paper
• Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry

  2003cited by this paper
• Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells.

  2003cited by this paper
• [Cell cycle regulation after exposure to ionizing radiation].

  1999cited by this paper
• Hypophosphorylated retinoblastoma protein is associated with G2 arrest in esophageal squamous cell carcinoma.

  1999cited by this paper
• Régulation du cycle cellulaire des cellules exposées aux radiations ionisantes

  1999cited by this paper
• Radiation-induced apoptosis mediated by retinoblastoma protein.

  1998cited by this paper
• Expression of transcription factor E2F1 induces quiescent cells to enter S phase

  1993cited by this paper
• Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.

  1991cited by this paper
• Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

  1990cited by this paper
• Computer programs for the analysis of cellular survival data.

  1987cited by this paper

• Multi-omics reveals that NOTCH1 promotes cervical cancer progression and reduces radiosensitivity

  2025cites this paper
• Exploring the therapeutic potential of natural products in modulating miRNA networks in prostate cancer

  2025cites this paper
• Identification and validation of the TRHDE‐AS1/hsa‐miR‐449a/ADAMTS5 axis as a novel prognostic biomarker in prostate cancer

  2024cites this paper
• Increasing prostate cancer radiosensitivity by miR-7-5p knockdown of anti-apoptotic genes.

  2024cites this paper
• MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancer

  2024cites this paper
• Cytotoxic Effects of Darinaparsin, a Novel Organic Arsenical, against Human Leukemia Cells

  2023cites this paper
• Inducing apoptosis by using microRNA in radio-resistant prostate cancer: an in-silico study with an in-vitro validation

  2023cites this paper
• Prostate cancer and microRNAs: New insights into apoptosis.

  2023cites this paper
• The role of microRNAs in the development of radioresistance of prostate cancer cells (experimental study)

  2022cites this paper
• The role of microRNA-induced apoptosis in diverse radioresistant cancers.

  2022cites this paper
• Improving the prediction for the response to radiotherapy of clinical tumor samples by using combinatorial model of MicroRNA expression

  2022cites this paper
• Prediction of Response to Radiotherapy by Characterizing the Transcriptomic Features in Clinical Tumor Samples across 15 Cancer Types

  2022cites this paper
• MicroRNA mediated therapeutic effects of natural agents in prostate cancer

  2021cites this paper
• microRNAs in the pathogenesis of non-obstructive azoospermia: the underlying mechanisms and therapeutic potentials

  2021cites this paper
• MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer

  2021cites this paper
• The Influence of miRNAs on Radiotherapy Treatment in Prostate Cancer – A Systematic Review

  2021cites this paper
• Emerging role of non-coding RNAs in response of cancer cells to radiotherapy.

  2020cites this paper
• microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation

  2020cites this paper
• Knockdown of lncRNA TUG1 Enhances Radiosensitivity of Prostate Cancer via the TUG1/miR-139-5p/SMC1A Axis

  2020cites this paper
• OTT_A_236860 2319..2331

  2020cites this paper
• MicroRNA-499 Suppresses the Growth of Hepatocellular Carcinoma by Downregulating Astrocyte Elevated Gene-1

  2020cites this paper
• MicroRNA-29b-3p enhances radiosensitivity through modulating WISP1-mediated mitochondrial apoptosis in prostate cancer cells

  2020cites this paper
• miRNAs and radiotherapy response in prostate cancer

  2020cites this paper
• Exogenous melatonin modulates carbon ion radiation-induced immune dysfunction in mice.

  2019cites this paper
• Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non‐small cell lung cancer by regulating miR‐449a/TGIF2 axis

  2019cites this paper
• MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution

  2019cites this paper
• PAQR4 promotes cell proliferation and metastasis through the CDK4-pRB-E2F1 pathway in non-small-cell lung cancer

  2019cites this paper
• PaQr4 promotes cell proliferation and metastasis through the cDK4-prB-e2F1 pathway in non-small-cell lung cancer

  2019cites this paper
• PaQr4 promotes cell proliferation and metastasis through the cDK4-prB-e2F1 pathway in non-small-cell lung cancer

  2019cites this paper
• miR‑589‑5p is downregulated in prostate cancer and regulates tumor cell viability and metastasis by targeting CCL‑5.

  2019cites this paper
• microRNA‐16‐5p enhances radiosensitivity through modulating Cyclin D1/E1–pRb–E2F1 pathway in prostate cancer cells

  2018cites this paper
• Circ-8073 regulates CEP55 by sponging miR-449a to promote caprine endometrial epithelial cells proliferation via the PI3K/AKT/mTOR pathway.

  2018cites this paper
• Tumor suppressor miR-449a inhibits the development of gastric cancer via down-regulation of SGPL1

  2018cites this paper
• Senescence-Associated MicroRNAs.

  2017cites this paper
• miR-449a: a potential therapeutic agent for cancer

  2017cites this paper
• CHK1 expression in Gastric Cancer is modulated by p53 and RB1/E2F1: implications in chemo/radiotherapy response

  2016cites this paper
• DNA damage response regulation by microRNAs as a therapeutic target in cancer.

  2016cites this paper